T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
W.P. Carey
WPC
$15B
| $68.3M | 0.01% |
1,082,219
+23,868
| +2% | +$1.51M |
|
627
Vertiv
VRT
$51.5B
| $68.1M | 0.01% |
943,617
-1,169,312
| -55% | -$84.4M |
|
628
Biohaven
BHVN
$1.47B
| $67.9M | 0.01% |
2,822,974
-589,217
| -17% | -$14.2M |
|
629
Option Care Health
OPCH
$4.62B
| $67.9M | 0.01% |
1,941,777
-10,080
| -0.5% | -$352K |
|
630
Constellation Brands
STZ
$24.6B
| $67.8M | 0.01% |
369,417
-1,095,658
| -75% | -$201M |
|
631
Watts Water Technologies
WTS
$9.39B
| $67.7M | 0.01% |
331,871
+772
| +0.2% | +$157K |
|
632
Agios Pharmaceuticals
AGIO
$2.14B
| $67.4M | 0.01% |
2,301,353
-122,184
| -5% | -$3.58M |
|
633
Disc Medicine
IRON
$2.08B
| $67.4M | 0.01% |
1,358,254
-36,383
| -3% | -$1.81M |
|
634
Douglas Emmett
DEI
$2.79B
| $67.1M | 0.01% |
4,195,729
+492,997
| +13% | +$7.89M |
|
635
Wynn Resorts
WYNN
$12.6B
| $66.7M | 0.01% |
799,247
-18,594
| -2% | -$1.55M |
|
636
Tenaris
TS
$18.7B
| $66.6M | 0.01% |
1,703,658
-171,673
| -9% | -$6.71M |
|
637
UFP Industries
UFPI
$5.78B
| $66.4M | 0.01% |
620,081
-17,338
| -3% | -$1.86M |
|
638
SPX Corp
SPXC
$9.21B
| $66.3M | 0.01% |
514,858
+2,505
| +0.5% | +$323K |
|
639
CorVel
CRVL
$4.39B
| $66.3M | 0.01% |
591,798
-33,814
| -5% | -$3.79M |
|
640
Royal Gold
RGLD
$12.5B
| $66.3M | 0.01% |
405,224
+15,167
| +4% | +$2.48M |
|
641
Payoneer
PAYO
$2.34B
| $65.6M | 0.01% |
8,970,295
+260,306
| +3% | +$1.9M |
|
642
Kroger
KR
$45.2B
| $65.3M | 0.01% |
965,081
+15,125
| +2% | +$1.02M |
|
643
Post Holdings
POST
$5.7B
| $64.8M | 0.01% |
556,982
+3,338
| +0.6% | +$388K |
|
644
NRG Energy
NRG
$31.9B
| $64.4M | 0.01% |
674,893
-3,001
| -0.4% | -$286K |
|
645
Protagonist Therapeutics
PTGX
$3.66B
| $63.9M | 0.01% |
1,322,006
-70,646
| -5% | -$3.42M |
|
646
Mirum Pharmaceuticals
MIRM
$3.73B
| $63.8M | 0.01% |
1,415,137
-7,592
| -0.5% | -$342K |
|
647
W.W. Grainger
GWW
$48B
| $63.6M | 0.01% |
64,401
-46,672
| -42% | -$46.1M |
|
648
Kadant
KAI
$3.69B
| $63.6M | 0.01% |
188,667
-2,730
| -1% | -$920K |
|
649
Americold
COLD
$3.93B
| $63.5M | 0.01% |
2,960,873
+2,783,264
| +1,567% | +$59.7M |
|
650
Rhythm Pharmaceuticals
RYTM
$6.39B
| $63.5M | 0.01% |
1,199,053
+513,901
| +75% | +$27.2M |
|